Indefinite Delivery Contract SPE2DR25D1200

The federal contract IDV award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a period of performance from August 1, 2025 to December 31, 2036 and supports normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness (PVR), and War Readiness Materiel (WRM) requirements for pharmaceutical products to the Defense Health Agency, Department of Defense, United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet. The contract encompasses a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The solicitation for this procurement, which is expected to be issued in March 2024, will be an unrestricted, fully competitive acquisition with awards made on a regional basis to at least three different contractors. The contract type is a firm-fixed price, requirements contract with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion.

Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs allow the government to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.